Genomics, heart failure and sudden cardiac death

Area of Science:

• Cardiology
• Genetics
• Genomic Medicine

Background:

• Sudden cardiac death (SCD) is a leading cause of mortality globally.
• Increasing prevalence of coronary disease and heart failure contributes to rising SCD rates.
• Current risk factors lack predictive power for identifying individuals at risk of fatal arrhythmias.

Purpose of the Study:

• To explore the potential of genomic science in identifying patients at high risk for SCD.
• To investigate how common genetic variants (polymorphisms) contribute to life-threatening cardiac arrhythmias.
• To improve risk stratification for SCD and guide the use of implantable cardioverter defibrillators (ICDs).

Main Methods:

• Review of recent advances in genomic medicine.
• Identification of candidate genes and pathways associated with SCD.
• Analysis of common polymorphisms predisposing to cardiac arrhythmias.

Main Results:

• Genomic medicine provides novel approaches to identify genetic predispositions to SCD.
• Common genetic polymorphisms can influence the initiation and propagation of lethal cardiac arrhythmias.
• Understanding these genetic links can enhance risk stratification for SCD.

Conclusions:

• Genomic science holds promise for identifying individuals at high risk of sudden cardiac death.
• Improved understanding of genetic polymorphisms can refine patient selection for interventions like ICDs.
• This research offers new insights into the pathophysiology of sudden cardiac death.